Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00188903
Status:
COMPLETED
Last Update Posted:
2010-08-05
First Post:
2005-09-13
Brief Title:
Diastolic Dysfunction and Atrial Fibrillation in CABG Surgery
Sponsor:
University Health Network Toronto
Organization:
University Health Network Toronto
Study Overview
Official Title:
Diastolic Dysfunction and Atrial Fibrillation in Patients Undergoing Coronary Revascularization Surgery
Status:
COMPLETED
Status Verified Date:
2008-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Left ventricular LV diastolic dysfunction is a common manifestation of heart disease that is responsible for significant morbidity and mortalityIt is present when the ventricular filling is impaired as a result of delayed relaxation or decreased compliance During Coronary artery bypass grafting CABG surgery LV diastolic dysfunction is a frequent occurrence Failure of the left ventricle to dilate normally causes an increase in LV filling pressure Atrial fibrillation AF is a common complication after cardiac surgery affecting 20-30 of patients undergoing coronary revascularization procedures AF is associated with significant morbidity and mortality and has been identified as a causative factor of increased length of both hospital and intensive care unit ICU stay after CABG surgery resulting in increased resource utilization and medical care costsThe primary aim of this study is to determine if patients with preoperative diastolic dysfunction are exposed to higher risk of AF after coronary revascularization surgery
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None